|
Clinical value of noninvasive biomarkers reflecting a collagen-rich stroma in metastatic melanoma patients treated with anti-PD1 therapy. |
|
|
Employment - Nordic Bioscience |
Research Funding - The Danish National Research Foundation |
|
|
No Relationships to Disclose |
|
|
Speakers' Bureau - Novartis; Pfizer |
Research Funding - Cristal Therapeutics (Inst); Novartis (Inst) |
Travel, Accommodations, Expenses - Ipsen |
|
|
No Relationships to Disclose |
|
|
Speakers' Bureau - Novartis |
Research Funding - Astellas Pharma (Inst); Bayer Holding (Inst); Boehringer Ingelheim (Inst); Cristal Therapeutics (Inst); Pamgene (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer |
|
|
Employment - Nordic Bioscience |
Research Funding - The Danish National Research Foundation |